One of the possible mechanisms of amyloid fibrils formation based on the sizes of primary and secondary folding nuclei of Aβ40 and Aβ42.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Journal of Structural Biology

• Publication date

  2016-06-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.jsb.2016.03.020PMID 27016282
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Amyloid-β adopts a conserved, partially folded structure upon binding to zwitterionic lipid bilayers prior to amyloid formation.

  2016cited by this paper
• Tools of the Trade: Investigations into Design Strategies of Small Molecules to Target Components in Alzheimer's Disease

  2015cited by this paper
• Probing the sources of the apparent irreproducibility of amyloid formation: drastic changes in kinetics and a switch in mechanism due to micellelike oligomer formation at critical concentrations of IAPP.

  2015cited by this paper
• High-resolution NMR characterization of low abundance oligomers of amyloid-β without purification

  2015cited by this paper
• Aβ(1–42) Fibril Structure Illuminates Self-recognition and Replication of Amyloid in Alzheimer’s

  2015cited by this paper
• Assembly of Aβ proceeds via monomeric nuclei.

  2015cited by this paper
• Studies of Polymorphism of Amyloid-β 42 Peptide from Different Suppliers

  2015cited by this paper
• Differences in nucleation behavior underlie the contrasting aggregation kinetics of the Aβ40 and Aβ42 peptides

  2014cited by this paper
• How to determine the size of folding nuclei of protofibrils from the concentration dependence of the rate and lag-time of aggregation. II. Experimental application for insulin and LysPro insulin: aggregation morphology, kinetics, and sizes of nuclei.

  2014cited by this paper
• How to determine the size of folding nuclei of protofibrils from the concentration dependence of the rate and lag-time of aggregation. I. Modeling the amyloid protofibril formation.

  2014cited by this paper
• The amyloid state and its association with protein misfolding diseases

  2014cited by this paper
• Aβ association inhibition by transferrin.

  2013cited by this paper
• Proliferation of amyloid-β42 aggregates occurs through a secondary nucleation mechanism

  2013cited by this paper
• Molecular structure of β-amyloid fibrils in Alzheimer's disease brain tissue.

  2013cited by this paper
• A clear view of polymorphism, twist, and chirality in amyloid fibril formation.

  2013cited by this paper
• Polymorph-specific kinetics and thermodynamics of β-amyloid fibril growth.

  2013cited by this paper
• Zinc stabilization of prefibrillar oligomers of human islet amyloid polypeptide.

  2013cited by this paper
• Computational assembly of polymorphic amyloid fibrils reveals stable aggregates.

  2013cited by this paper
• Pulsed hydrogen–deuterium exchange mass spectrometry probes conformational changes in amyloid beta (Aβ) peptide aggregation

  2013cited by this paper
• Insights into Bacteriophage T5 Structure from Analysis of Its Morphogenesis Genes and Protein Components

  2013cited by this paper
• C-terminal turn stability determines assembly differences between Aβ40 and Aβ42.

  2013cited by this paper
• Fiber diffraction data indicate a hollow core for the Alzheimer's aβ 3-fold symmetric fibril.

  2012cited by this paper
• Toxic fibrillar oligomers of amyloid-β have cross-β structure

  2012cited by this paper
• Structural Basis for Increased Toxicity of Pathological Aβ42:Aβ40 Ratios in Alzheimer Disease*

  2011cited by this paper
• The role of β-amyloid peptide in neurodegenerative diseases.

  2011cited by this paper
• Structural preferences of Aβ fragments in different micellar environments.

  2011cited by this paper
• Stoichiometry and affinity of the human serum albumin-Alzheimer's Aβ peptide interactions.

  2011cited by this paper
• A multistage pathway for human prion protein aggregation in vitro: from multimeric seeds to β-oligomers and nonfibrillar structures.

  2011cited by this paper
• A partially folded structure of amyloid-beta(1-40) in an aqueous environment.

  2011cited by this paper
• Amyloid structure: conformational diversity and consequences.

  2011cited by this paper
• Amyloid β-protein aggregation produces highly reproducible kinetic data and occurs by a two-phase process.

  2010cited by this paper
• Structural conversion of neurotoxic amyloid-β(1–42) oligomers to fibrils

  2010cited by this paper
• Seeded growth of β-amyloid fibrils from Alzheimer's brain-derived fibrils produces a distinct fibril structure

  2009cited by this paper
• An Analytical Solution to the Kinetics of Breakable Filament Assembly

  2009cited by this paper
• Structural polymorphism of Alzheimer Aβ and other amyloid fibrils

  2009cited by this paper
• Structure–neurotoxicity relationships of amyloid β-protein oligomers

  2009cited by this paper
• Association of highly compact type II diabetes related islet amyloid polypeptide intermediate species at physiological temperature revealed by diffusion NMR spectroscopy.

  2009cited by this paper
• A New Function of Human HtrA2 as an Amyloid-β Oligomerization Inhibitor

  2009cited by this paper
• Interprotofilament interactions between Alzheimer's Aβ1–42 peptides in amyloid fibrils revealed by cryoEM

  2009cited by this paper
• Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory

  2008cited by this paper
• Molecular structural basis for polymorphism in Alzheimer's β-amyloid fibrils

  2008cited by this paper
• Amyloid-β Aggregation

  2007cited by this paper
• Amyloid-beta aggregation.

  2007cited by this paper
• Protein misfolding, functional amyloid, and human disease.

  2006cited by this paper
• Amyloidogenic self-assembly of insulin aggregates probed by high resolution atomic force microscopy.

  2005cited by this paper
• Self-Propagating, Molecular-Level Polymorphism in Alzheimer's ß-Amyloid Fibrils

  2005cited by this paper
• 3D structure of Alzheimer's amyloid-beta(1-42) fibrils.

  2005cited by this paper
• 3D structure of Alzheimer's amyloid-β(1–42) fibrils

  2005cited by this paper
• Self-propagating, molecular-level polymorphism in Alzheimer's beta-amyloid fibrils.

  2005cited by this paper
• Amyloid ion channels: a common structural link for protein-misfolding disease.

  2005cited by this paper
• Oxidative metabolites accelerate Alzheimer's amyloidogenesis by a two-step mechanism, eliminating the requirement for nucleation.

  2005cited by this paper
• Principles of protein folding, misfolding and aggregation.

  2004cited by this paper
• Mixtures of wild-type and a pathogenic (E22G) form of Abeta40 in vitro accumulate protofibrils, including amyloid pores.

  2003cited by this paper
• Abeta protofibrils possess a stable core structure resistant to hydrogen exchange.

  2003cited by this paper
• Increasing the precision of comparative models with YASARA NOVA—a self‐parameterizing force field

  2002cited by this paper
• Amyloid fibers are water-filled nanotubes

  2002cited by this paper
• Electron microscopy of prefibrillar structures and amyloid fibrils.

  1999cited by this paper
• Heparan sulfate expression patterns in the amyloid deposits of patients with Alzheimer's and Lewy body type dementia.

  1993cited by this paper

• Differentiating Alzheimer’s Aβ Isoforms Coaggregated in Cerebrospinal Fluid via Single-Particle Imaging

  2026cites this paper
• Structural convergence and membrane interactions of Aβ1-42 along the primary nucleation process studied by solid state NMR

  2025cites this paper
• Amyloid β fragments that suppress oligomers but not fibrils are cytoprotective.

  2025cites this paper
• Deriving kinetic parameters of amyloid aggregation from concentration dependence of lag phase

  2025cites this paper
• Lipid–polymer hybrid-vesicles interrupt nucleation of amyloid fibrillation

  2024cites this paper
• The Strategies of Development of New Non-Toxic Inhibitors of Amyloid Formation

  2023cites this paper
• Aggregation Dynamics Characteristics of Seven Different Aβ Oligomeric Isoforms-Dependence on the Interfacial Interaction.

  2023cites this paper
• Role of sugar osmolytes and their nano-counterparts as inhibitors in protein fibrillation

  2023cites this paper
• Inherent Adaptivity of Alzheimer Peptides to Crowded Environments.

  2023cites this paper
• Therapeutic potential for amyloid surface inhibitor: only amyloid‐β oligomers formed by secondary nucleation disrupt lipid membrane integrity

  2022cites this paper
• Influence of Chaperones on Amyloid Formation of Аβ Peptide.

  2022cites this paper
• Multiple Antimicrobial Effects of Hybrid Peptides Synthesized Based on the Sequence of Ribosomal S1 Protein from Staphylococcus aureus

  2022cites this paper
• Mechanism of Amyloid Gel Formation by Several Short Amyloidogenic Peptides

  2021cites this paper
• Amyloidogenic Propensities of Ribosomal S1 Proteins: Bioinformatics Screening and Experimental Checking

  2020cites this paper
• Oligomerization and Conformational Change Turn Monomeric β-Amyloid and Tau Proteins Toxic: Their Role in Alzheimer’s Pathogenesis

  2020cites this paper
• Distinguishing the Effect on the Rate and Yield of Aβ42 Aggregation by Green Tea Polyphenol EGCG

  2020cites this paper
• Apolipoprotein E impairs amyloid‐β fibril elongation and maturation

  2020cites this paper
• Oligomers Are Promising Targets for Drug Development in the Treatment of Proteinopathies

  2020cites this paper
• Inhibition of Aβ1-42 fibrillation by chaperonins: human Hsp60 is a stronger inhibitor than its bacterial homologue GroEL.

  2019cites this paper
• Key Peptides and Proteins in Alzheimer's Disease.

  2019cites this paper
• New Mechanism of Amyloid Fibril Formation.

  2019cites this paper
• The binding of monomeric amyloid β peptide to serum albumin is affected by major plasma unsaturated fatty acids.

  2019cites this paper
• Aβ42 fibril formation from predominantly oligomeric samples suggests a link between oligomer heterogeneity and fibril polymorphism

  2019cites this paper
• formation from predominantly oligomeric samples suggests a between oligomer heterogeneity and fibril polymorphism.

  2019cites this paper
• To Be Fibrils or To Be Nanofilms? Oligomers Are Building Blocks for Fibril and Nanofilm Formation of Fragments of Aβ Peptide.

  2018cites this paper
• What is Responsible for Atypical Dependence of the Rate of Amyloid Formation on Protein Concentration: Fibril-Catalyzed Initiation of New Fibrils or Competition with Oligomers?

  2018cites this paper
• Anomalous Kinetics of Amyloidogenesis Suggest a Competition between Oligomers and Fibrils

  2018cites this paper
• Studies of the Process of Amyloid Formation by Aβ Peptide

  2018cites this paper
• [Molecular mechanism of amyloid formation by Ab peptide: review of own works].

  2018cites this paper
• Effect of Differences in the Primary Structure of the A-Chain on the Aggregation of Insulin Fragments

  2018cites this paper
• Should the Treatment of Amyloidosis Be Personified? Molecular Mechanism of Amyloid Formation by Aβ Peptide and Its Fragments

  2018cites this paper
• Ascorbic acid inhibits human insulin aggregation and protects against amyloid induced cytotoxicity.

  2017cites this paper
• Rosetta Stone for Amyloid Fibrils: The Key Role of Ring-Like Oligomers in Amyloidogenesis

  2017cites this paper
• Protein aggregation, misfolding and consequential human neurodegenerative diseases

  2017cites this paper
• Amyloidogenic motifs revealed by n-gram analysis

  2017cites this paper
• Self-Assembly Pathways of β-Sheet-Rich Amyloid-β(1-40) Dimers: Markov State Model Analysis on Millisecond Hybrid-Resolution Simulations.

  2017cites this paper
• Structural model of amyloid fibrils for amyloidogenic peptide from Bgl2p-glucantransferase of S. cerevisiae cell wall and its modifying analog. New morphology of amyloid fibrils.

  2016cites this paper
• Multi-Targeting Derivatives For Alzheimer’s Disease: Utilization of Quinazoline Ring Scaffolds

  2016cites this paper
• X-ray diffraction and electron microscopy data for amyloid formation of Aβ40 and Aβ42

  2016cites this paper
• Peptide Aβ(16-25) forms nanofilms in the process of its aggregation

  2016cites this paper
• Determination of regions involved in amyloid fibril formation for Aβ(1-40) peptide

  2016cites this paper
• The Mechanism Underlying Amyloid Polymorphism is Opened for Alzheimer’s Disease Amyloid-β Peptide

  2016cites this paper